| Dr Sharya Vaughan Bourdet, | |
|
Pharmacy Service (119) Vamc, 4150 Clement St, San Francisco, CA 94121-1545 | |
| (415) 221-4810 | |
| Not Available |
| Full Name | Dr Sharya Vaughan Bourdet |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | Pharmacy Service (119) Vamc, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093728396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH 52102 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sharya Vaughan Bourdet, 614 Bayview Ave, Millbrae, CA 94030-1159 Ph: (650) 952-3855 | Dr Sharya Vaughan Bourdet, Pharmacy Service (119) Vamc, 4150 Clement St, San Francisco, CA 94121-1545 Ph: (415) 221-4810 |
News Archive
Science Exchange, in partnership with the open-access publisher PLOS and open data repository figshare, announced today the launch of the Reproducibility Initiative - a new program to help scientists, institutions and funding agencies validate their critical research findings.
Wake Forest Institute for Regenerative Medicine researchers have shown the feasibility of bioengineering vascularized functional renal tissues for kidney regeneration, developing a partial augmentation strategy that may be a more feasible and practical approach than creating whole organs.
Epilepsy prevalence and incidence is greater than earlier thought in the United States. The latest study shows that one in every 26 people in the United States will develop epilepsy at some point in their life. Experts believe this new revelation calls for more attention and funding for the disease.
The global toll of the disabling eye disease glaucoma is set to reach 60 million by 2010, rising to almost 80 million by 2020, finds research in the British Journal of Ophthalmology.
Uroplasty, Inc. highlighted results from a two-year, multicenter clinical study of Macroplastique that will be published in the April 2010 print edition of The Journal of Urology(R). The 24-month study evaluated the durability of Macroplastique for stress urinary incontinence in women with previously documented success at 12 months. Substantial, durable results were sustained during 2 years with 84% of patients maintaining significant improvement from their 12-month assessment. Additionally, 67% of the patients implanted with Macroplastique were dry at the 24-month follow-up visit.
› Verified 4 days ago
Christie Biggins, PHD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3398 Mission St, San Francisco, CA 94110 Phone: 415-824-6886 | |
Hayley Park, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Saint Francis Pl, Apt 3406, San Francisco, CA 94107 Phone: 312-758-7223 | |
Tina R Li, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1230 Powell St, San Francisco, CA 94133 Phone: 650-303-1987 Fax: 415-781-8788 | |
Miss Lara Berger, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Pine Street, San Francisco, CA 94108 Phone: 415-362-6318 Fax: 415-362-6563 | |
Ken Lapto Choi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 33rd Ave, San Francisco, CA 94121 Phone: 415-519-6295 | |
Kira Ostapenko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5614 Geary Blvd, San Francisco, CA 94121 Phone: 415-752-3737 | |
Danielle Renee Weaver, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Gene Friend Way Apt 614, San Francisco, CA 94158 Phone: 717-332-3863 |